Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

Biocon Biologics Device

Class 5Status: Objected
Trademark Logo
Application Number6110093
Trademark Status
Objected
Trademark Class5
Application Date2023-09-14
Proprietor NameBIOCON BIOLOGICS LIMITED
Appropriate OfficeCHENNAI
StateKARNATAKA
Trademark TypeDEVICE
User Details09/08/2019
Agent NameSAIKRISHNA & ASSOCIATES[9287]
Agent AddressB-140, SEC-51, NOIDA-201301
Goods And Services Details[CLASS : 5] Pharmaceuticals and medical preparations, Pharmaceutical preparations used for treatment in the field of diabetology, oncology, nephrology, endocrinology, immunology and metabolic disorders; Pharmaceutical preparations used in treatment of diabetes, cancer, renal disorder, heart diseases, autoimmune diseases, bacterial and viral infections.Associated Trademarks 4281044

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about Biocon Biologics Device.

The current status of trademark application 6110093 for Biocon Biologics Device is Objected.
Biocon Biologics Device is registered under trademark class 5.
The proprietor of Biocon Biologics Device is BIOCON BIOLOGICS LIMITED.
Trademark application 6110093 for Biocon Biologics Device was filed on 2023-09-14.